Net profit of ERIS Lifesciences rose 32.11% to Rs 93.84 crore in the quarter ended March 2025 as against Rs 71.03 crore during the previous quarter ended March 2024. Sales rose 28.38% to Rs 702.60 crore in the quarter ended March 2025 as against Rs 547.27 crore during the previous quarter ended March 2024.
For the full year,net profit declined 10.26% to Rs 351.84 crore in the year ended March 2025 as against Rs 392.05 crore during the previous year ended March 2024. Sales rose 44.59% to Rs 2879.26 crore in the year ended March 2025 as against Rs 1991.30 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 702.60 | 547.27 | 28 | 2879.26 | 1991.30 | 45 |
| OPM % | 35.92 | 27.12 | - | 35.33 | 33.89 | - |
| PBDT | 206.12 | 130.55 | 58 | 804.33 | 613.85 | 31 |
| PBT | 128.87 | 76.75 | 68 | 488.87 | 431.34 | 13 |
| NP | 93.84 | 71.03 | 32 | 351.84 | 392.05 | -10 |